Ubs Group Ag Trans Medics Group, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 59,252 shares of TMDX stock, worth $4.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,252

Previous 32,411 82.81%

Holding current value

$4.3 Million

Previous $4.88 Million 90.58%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$135.68 - $176.11 $3.64 Million - $4.73 Million	26,841 Added 82.81%	59,252 $9.3 Million
Q2 2024 Aug 13, 2024	SELL	$72.62 - $150.62 $928,664 - $1.93 Million	-12,788 Reduced 28.29%	32,411 $4.88 Million
Q1 2024 May 13, 2024	BUY	$70.86 - $89.93 $349,764 - $443,894	4,936 Added 12.26%	45,199 $3.34 Million
Q4 2023 Feb 09, 2024	BUY	$36.74 - $81.08 $599,192 - $1.32 Million	16,309 Added 68.08%	40,263 $3.18 Million
Q3 2023 Nov 09, 2023	BUY	$53.47 - $96.07 $1.12 Million - $2.01 Million	20,904 Added 685.38%	23,954 $1.31 Million
Q2 2023 Aug 11, 2023	SELL	$66.23 - $88.73 $747,471 - $1 Million	-11,286 Reduced 78.72%	3,050 $256,000
Q1 2023 May 12, 2023	BUY	$53.63 - $82.33 $239,833 - $368,179	4,472 Added 45.34%	14,336 $1.09 Million
Q4 2022 Feb 08, 2023	BUY	$39.08 - $64.29 $265,196 - $436,271	6,786 Added 220.47%	9,864 $608,000
Q3 2022 Nov 10, 2022	SELL	$31.56 - $55.75 $18,178 - $32,112	-576 Reduced 15.76%	3,078 $128,000
Q2 2022 Aug 10, 2022	SELL	$20.56 - $32.15 $205,373 - $321,146	-9,989 Reduced 73.22%	3,654 $115,000
Q1 2022 May 16, 2022	SELL	$12.58 - $26.94 $147,085 - $314,982	-11,692 Reduced 46.15%	13,643 $367,000
Q4 2021 Feb 14, 2022	BUY	$19.16 - $32.68 $427,459 - $729,090	22,310 Added 737.52%	25,335 $486,000
Q3 2021 Nov 15, 2021	BUY	$25.92 - $34.51 $17,496 - $23,294	675 Added 28.72%	3,025 $100,000
Q2 2021 Aug 13, 2021	SELL	$21.63 - $40.07 $25,934 - $48,043	-1,199 Reduced 33.78%	2,350 $78,000
Q1 2021 May 12, 2021	SELL	$17.75 - $47.82 $101,689 - $273,960	-5,729 Reduced 61.75%	3,549 $148,000
Q4 2020 Feb 11, 2021	BUY	$11.91 - $19.9 $18,436 - $30,805	1,548 Added 20.03%	9,278 $184,000
Q3 2020 Nov 12, 2020	SELL	$13.78 - $18.84 $81,136 - $110,929	-5,888 Reduced 43.24%	7,730 $106,000
Q2 2020 Jul 31, 2020	SELL	$11.66 - $18.26 $10,447 - $16,360	-896 Reduced 6.17%	13,618 $244,000
Q1 2020 May 01, 2020	SELL	$10.5 - $20.2 $87,465 - $168,266	-8,330 Reduced 36.46%	14,514 $175,000
Q4 2019 Feb 14, 2020	BUY	$16.61 - $21.64 $188,490 - $245,570	11,348 Added 98.71%	22,844 $434,000
Q3 2019 Nov 14, 2019	BUY	$20.27 - $28.93 $95,269 - $135,971	4,700 Added 69.16%	11,496 $273,000
Q2 2019 Aug 14, 2019	BUY	$22.36 - $30.41 $151,958 - $206,666	6,796 New	6,796 $197,000

Others Institutions Holding TMDX

# of Institutions

398

Shares Held

31.7M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.31B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account